SAMBATARO, GIANLUCA
 Distribuzione geografica
Continente #
NA - Nord America 3.459
AS - Asia 2.599
EU - Europa 2.037
SA - Sud America 333
AF - Africa 300
OC - Oceania 1
Totale 8.729
Nazione #
US - Stati Uniti d'America 3.401
SG - Singapore 1.186
RU - Federazione Russa 988
CN - Cina 885
IT - Italia 491
BR - Brasile 287
CI - Costa d'Avorio 228
KR - Corea 219
IE - Irlanda 177
DE - Germania 123
VN - Vietnam 119
FI - Finlandia 73
IN - India 71
GB - Regno Unito 61
CA - Canada 37
AR - Argentina 26
JP - Giappone 24
NL - Olanda 23
BJ - Benin 22
FR - Francia 20
BD - Bangladesh 19
SN - Senegal 18
MX - Messico 16
PL - Polonia 15
SE - Svezia 13
UA - Ucraina 13
CZ - Repubblica Ceca 11
ZA - Sudafrica 11
HK - Hong Kong 10
ID - Indonesia 10
IR - Iran 8
NG - Nigeria 8
TR - Turchia 8
ES - Italia 7
EC - Ecuador 6
AT - Austria 5
BE - Belgio 5
CO - Colombia 5
IQ - Iraq 5
MA - Marocco 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 3
CL - Cile 3
KE - Kenya 3
LT - Lituania 3
PY - Paraguay 3
UZ - Uzbekistan 3
AO - Angola 2
CY - Cipro 2
GR - Grecia 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
NP - Nepal 2
SA - Arabia Saudita 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
GY - Guiana 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
LU - Lussemburgo 1
MY - Malesia 1
OM - Oman 1
PH - Filippine 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
TL - Timor Orientale 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 8.729
Città #
Singapore 715
Dallas 705
Santa Clara 705
Hefei 443
Moscow 422
Chicago 230
Abidjan 228
Seoul 219
Chandler 218
Ashburn 193
Los Angeles 189
Dublin 177
Boardman 120
San Jose 108
Munich 105
Beijing 100
Catania 76
Civitanova Marche 72
New York 67
Kochi 51
Buffalo 40
Palermo 37
Ho Chi Minh City 36
Cambridge 34
Helsinki 34
Lawrence 34
Andover 32
Hanoi 24
Lappeenranta 24
Cotonou 22
Des Moines 22
São Paulo 21
Dong Ket 20
Dakar 18
Milan 18
Amsterdam 17
Tokyo 17
Montreal 16
San Francisco 16
Brooklyn 15
Messina 14
Nanjing 14
Phoenix 14
Denver 13
Jacksonville 13
Warsaw 13
Orem 12
Toronto 12
Wilmington 12
Bari 11
London 11
Poplar 11
Stockholm 11
Boston 10
Bremen 10
San Giovanni la Punta 10
Ferentino 9
Hong Kong 9
Johannesburg 9
Manchester 9
Seattle 9
Turku 9
Abuja 8
Reggio Emilia 8
Shanghai 8
Tehran 8
Woodbridge 8
Brno 7
Falls Church 7
Rome 7
Council Bluffs 6
Porto Alegre 6
Saint Petersburg 6
The Dalles 6
Washington 6
Atlanta 5
Charlotte 5
Columbus 5
Dhaka 5
Guangzhou 5
Guarulhos 5
Haiphong 5
Houston 5
Mumbai 5
Nuremberg 5
Paris 5
Querétaro 5
Rio de Janeiro 5
Ankara 4
Assago 4
Casablanca 4
Changsha 4
Chennai 4
Forlì 4
Hirosaki 4
Jyväskylä 4
Latina 4
New Delhi 4
Pennisi 4
Redondo Beach 4
Totale 6.089
Nome #
Pulmonary Vasculitides: A Radiological Review Emphasizing Parenchymal HRCT Features 252
Assessment of survival in patients with idiopathic pulmonary fibrosis using quantitative HRCT indexes 181
An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies 143
Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients 140
Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial essay 134
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 133
A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies 132
INVOLVEMENT OF OXIDATIVE STRESS AND VITAMINS D,C AND A IN SYSTEMIC SCLEROSIS: IN RELATION TO CLINICAL DISEASE ACTIVITY PARAMETERS 129
Chest imaging using signs, symbols, and naturalistic images: a practical guide for radiologists and non-radiologists 128
Assessment of Lung Cancer Development in Idiopathic Pulmonary Fibrosis Patients Using Quantitative High-Resolution Computed Tomography: A Retrospective Analysis 127
Comorbidities of IPF: How do they impact on prognosis 125
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 122
"Usual" interstitial pneumonia with autoimmune features: a prospective study on a cohort of idiopathic pulmonary fibrosis patients 122
Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them? 115
Interstitial Lung Disease in patients with Polymyalgia Rheumatica: A case series 114
Cryptogenic organizing pneumonia: Evolution of morphological patterns assessed by HRCT 114
Clinical and Prognostic Significance of p-ANCA Positivity in Idiopathic Pulmonary Fibrosis: A Retrospective Observational Study 113
COMPARISON BETWEEN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS AND INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES: A PROSPECTIVE COHORT 113
Myositis-Specific and Myositis-Associated Antibodies in Fibromyalgia Patients: A Prospective Study 110
State of the art in interstitial pneumonia with autoimmune features: A systematic review on retrospective studies and suggestions for further advances 107
Aortic root dilation in associated with the reduction in capillary density observed at nailfold capillaroscopy in SSc patients 107
Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis 105
Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases 105
Performance of radiomics features in the quantification of idiopathic pulmonary fibrosis from HRCT 104
Quantitative Evaluation of Fibrosis in IPF Patients: Meaning of Diffuse Pulmonary Ossification 104
Radiological Insights into UIP Pattern: A Comparison Between IPF and Non-IPF Patients 103
Clinical Presentation of Connective Tissue Disease Patients with and without Interstitial Lung Disease: A Retrospective Study 102
Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sjӧgren's syndrome: A systematic review from the Italian Society of Rheumatology 101
Quantitative assessment of interstitial lung disease in Sjögren’s syndrome 100
Nailfold videocapillaroscopy is a useful tool to recognize definite forms of systemic sclerosis and idiopathic inflammatory myositis in interstitial lung disease patients 100
Reduction of carotid baroreceptor sensitivity in systemic sclerosis 98
Histogram-based analysis in progressive pulmonary fibrosis: relationships between pulmonary functional tests and HRCT indexes 98
The Morphological Domain Does Not Affect the Rate of Progression to Defined Autoimmune Diseases in Patients With Interstitial Pneumonia With Autoimmune Features 97
The Impaired Elasticity of Large Arteries in Systemic Sclerosis Patients 96
Heart Valve Abnormalities in Systemic Sclerosis Patients: A Multicenter Cohort Study and Review of the Literature 95
Developing PI3K Inhibitors for Respiratory Diseases 93
Pharmacological treatment in Idiopathic Pulmonary Fibrosis: currentissues and future perspectives 92
Calcineurin inhibitor-based immunosuppression and COVID-19: Results from a multidisciplinary cohort of patients in Northern Italy 90
Emerging potential for bisphosphonates in the treatment of axial spondyloarthritis 89
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 85
Evaluation of changes in cardiac longitudinal strain rate in patients with systemic sclerosis undergoing iloprost treatment: an observational study 84
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases 82
Rethinking the need for increased clinical and radiological awareness of incidentally discovered interstitial lung abnormalities on CT chest 81
Alexithymia, mood states and pain experience in systemic lupus erythematosus and rheumatoid arthritis 81
Systemic Sclerosis and Idiopathic Portal Hypertension: Report of a Case and Review of the Literature 81
Point of care antibody detection assays for past SARS-CoV-2 infection are accurate over the time 76
Nocturnal nasal high-flow oxygen therapy in elderly patients with concomitant chronic obstructive pulmonary disease and obstructive sleep apnea 76
Highlights on Future Treatments of IPF: Clues and Pitfalls 75
A die-hard giant capillary 75
Towards Early Diagnosis of Mixed Connective Tissue Disease: Updated Perspectives 73
Use of Remdesivir in Patients Hospitalized for COVID-19 Pneumonia: Effect on the Hypoxic and Inflammatory State 73
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the {COVAD} surveys 72
Interstitial Pneumonia with Autoimmune Features (IPAF): time to redefine the classification criteria 72
Feasibility, face, and content validity of quantitative computed tomography in interstitial lung disease related to connective tissue diseases 71
The Pattern and Progression of "Usual" Interstitial Pneumonia with Autoimmune Features: Comparison with Patients with Classic Interstitial Pneumonia with Autoimmune Features and Idiopathic Pulmonary Fibrosis 71
Impact of {COVID}-19 outbreak in an Italian cohort of patients with systemic sclerosis 69
Targeting intracellular pathways in idiopathic inflammatory myopathies: A narrative review 69
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 69
Autoimmunity in Interstitial Lung Disease 68
Is there any role for thoracic ultrasound for interstitial lung disease underlying rheumatologic conditions? 68
Vitamin D Impacts on Skeletal Muscle Dysfunction in Patients with COPD Promoting Mitochondrial Health 67
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol 67
Is there any role for thoracic ultrasound for interstitial lung disease underlying rheumatologic conditions? Reply 67
Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review 66
Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study 65
Direct-acting Antivirals Inducing HCV-RNA Sustained Suppression Improve Xerophthalmia in HCV-infected Patients 65
The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak 65
Eosinophilic Interstitial Pneumonia 64
Tumoural calcinosis of the spine in the course of systemic sclerosis: Report of a new case and review of the literature 63
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis from the CLASS project 63
Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis 63
Quantification of ground glass opacities can be useful to describe disease activity in systemic sclerosis 63
High NEMO score values in nailfold videocapillaroscopy are associated with the subsequent development of ischaemic digital ulcers in patients with systemic sclerosis 62
Systemic lupus erythematosus patients with and without neuropsychiatric manifestations: a neck and transcranial duplex sonography study 61
Neck circumference as reliable predictor of mechanical ventilation support in adult inpatients with COVID-19: A multicentric prospective evaluation 61
Present and future of biologic drugs in primary Sjögren’s syndrome 61
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys 60
NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: A comparison with the proposed composite indices for this disease status entity 59
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey 59
{COVAD} survey 2 long-term outcomes: unmet need and protocol 59
Hepatic PPARs: their role in liver physiology, fibrosis and treatment 58
Primary-Sjögren’s-Syndrome-Related Interstitial Lung Disease: A Clinical Review Discussing Current Controversies 58
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group 58
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey 57
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study 57
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 56
Editorial: Multidisciplinary approach to interstitial lung disease associated with systemic rheumatic diseases 55
COVID-19 vaccination in autoimmune diseases (COVAD) study: Vaccine safety and tolerance in rheumatoid arthritis 55
Interstitial lung disease and anti-myeloperoxidase antibodies: Not a simple association 55
COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies 52
Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis 52
The cumulative number of micro-haemorrhages and micro-thromboses in nailfold videocapillaroscopy is a good indicator of disease activity in systemic sclerosis: A validation study of the NEMO score 51
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study 50
Subclinical carotid atherosclerosis in elderly patients with primary Sjögren syndrome: a duplex Doppler sonographic study 49
Quantitative chest tomography indexes are related to disease activity in systemic sclerosis: results from a cross-sectional study 49
Prevalence of Progressive Fibrosing Interstitial Lung Disease in Patients with Primary Sjogren Syndrome 48
Reply to J. Magalon et al 47
Letter to editor: “Interstitial pneumonia with autoimmune features: Clinical, radiologic and histological characteristics and outcome in a series of 57 patients” 47
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study 47
Darier's disease and rheumatoid arthritis: a new association and a review of the literature 46
Totale 8.411
Categoria #
all - tutte 31.592
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.592


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202164 0 0 0 0 0 0 21 3 18 2 4 16
2021/2022234 6 38 3 16 43 6 36 11 6 6 3 60
2022/2023688 37 55 6 63 68 93 21 110 150 16 41 28
2023/2024655 24 72 83 34 31 136 4 28 6 43 104 90
2024/20252.656 45 352 127 177 479 405 116 63 167 174 277 274
2025/20264.404 388 737 901 296 823 1.136 123 0 0 0 0 0
Totale 8.905